Benzinga | Apr 27, 2021 12:06PM EDT

Cassava Sciences Shares Up 4.5%; Maxim Group Issues Note Titled 'Aducanumab PDUFA in June, AAIC In July AD Space Looks Busy Ahead and Simufilam Should be in the Discussion'